|
Dr. Sarkar’s research focuses on understanding how the tumor microenvironment (TME) drives tumor progression and therapeutic resistance in breast cancer. Using integrated in vitro, in vivo, and organoid models, her work aims to define the cellular and molecular mechanisms by which the TME regulates cancer cell behavior and treatment response.
Her recent work (Oncogene, 2025) on the impact of circadian disruption (e.g., shift work and jet lag) on aggressive mammary tumorigenesis has been featured in Forbes and over 100 media outlets worldwide. Her research is supported by grants from the National Cancer Institute, the National Institute of General Medical Sciences, and the National Institute of Environmental Health Sciences. Dr. Sarkar is deeply committed to educational excellence, actively mentoring undergraduate and graduate students and postdoctoral fellows from diverse backgrounds, guiding them toward successful careers in medicine and biomedical research.
Dr. Sarkar has been a member of the ASIP since 2017 and is the recipient of the 2026 Fred Sanfilippo-ASIP Visiting Lectureship Award, recognizing her outstanding contributions and potential as a rising leader in cancer biology. She has been nominated as a 2026 TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) Protégé and was the recipient of the 2024 Southeastern Conference Visiting Faculty Award.
Connect with Dr. Sarkar on LinkedIn, and follow Women in Pathology on Facebook, X, and Instagram.
|